Previous 1 2 3 4 5 Next
'Good report card' for bioscience effort
Arizona's bioscience industry is growing in large part from a unique degree of collaboration among bioscience leaders, many of them from the Northeast Valley. (Thu, 07 Dec 2006 06:38:50 GMT)
Genome institute to help innovators with start-up funds
By Lola Nayar, New Delhi, Dec 7: India's premier Institute of Genomics and Integrative Biology (IGIB) is planning to launch a scheme to attract and help innovators in biotech and biogenomics start their own enterprise. (Thu, 07 Dec 2006 06:56:36 GMT)
Genome institute to help innovators with start-up funds
New Delhi, Dec 7 (IANS) India's premier Institute of Genomics and Integrative Biology (IGIB) is planning to launch a scheme to attract and help innovators in biotech and biogenomics start their own enterprise. (Thu, 07 Dec 2006 07:05:49 GMT)
PanGenetics B.V. Licenses Therapeutic Antibody for Treatment of Pain from Lay Line Genomics S.p.A.
UTRECHT, The Netherlands & CAMBRIDGE, England & ROME, Italy----PanGenetics B.V. and Lay Line Genomics S.p.A. jointly announced today that the companies have entered into a collaboration in the field of therapeutic antibodies for the treatment of pain. (Thu, 07 Dec 2006 09:00:00 GMT)
The world's strongest man
Augie Nieto is losing muscle to Lou Gehrig's disease. Now, he's tougher than ever. (Thu, 07 Dec 2006 11:07:22 GMT)
Tearing Down The Fungal Cell Wall
Scientists at the Virginia Bioinformatics Institute and Duke University Medical Center have pinpointed a fungal gene that appears to play an important role in the development and virulence of Alternaria brassicicola, a destructive fungal pathogen that results in considerable leaf loss in many economically important crops worldwide, including canola, cabbage and broccoli. (Thu, 07 Dec 2006 11:10:44 GMT)
Protein-based Tumor Biomarker Predicts Breast-cancer Survival
The first and largest clinical trial of its kind confirms that a protein called p27 may be a valuable tool for predicting survival after a diagnosis of breast cancer. (Thu, 07 Dec 2006 11:10:54 GMT)
Cedars-Sinai Medical Center Deploys Sun Compute Grid to Uncover New Ways to Treat Diseases
Sun Microsystems , the creator of the Solaris Operating System , announced today that Cedars-Sinai Medical Center is now using a Sun Grid Rack system, comprised of 400 Sun Fire x64 servers, Sun StorageTek solutions, Sun N1 software and pre-integrated by Sun Customer Ready Systems, to process and analyze vast amounts of complex data in the pursuit of medical discoveries that could lead to new (Thu, 07 Dec 2006 14:00:00 GMT)
Nanotechnology-Based Products To Accelerate Drug Discovery Developments
Research and Markets has announced the addition of "The Role of Nanotechnology in European Drug Discovery" to their offering (Thu, 07 Dec 2006 14:10:23 GMT)
Cedars-Sinai Medical Center Deploys Sun Compute Grid to Uncover New Ways to Treat Diseases
SANTA CLARA, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Sun Microsystems ( Nachrichten / Aktienkurs ), the creator of the Solaris(TM) Operating System (OS), announced today that Cedars-Sinai Medical Center is now using a Sun(TM) Grid Rack system, comprised of 400 Sun Fire(TM) x64 servers, Sun StorageTek(TM) solutions, Sun N1(TM) software and pre-integrated by Sun Customer Ready Systems, to process (Thu, 07 Dec 2006 14:15:42 GMT)
Accelrys To Release SciTegic Pipeline Pilot 6.0, The Scientific Operating Platform For Discovery And Development
Accelrys, Inc., a provider of scientific software and services, announced the sixth generation of SciTegic Pipeline Pilot, a platform for scientific discovery and development. Pipeline Pilot 6.0 features major new functionality in the areas of image analysis and bioinformatics, while enterprise enhancements make it easier to define and deploy protocols to a broader audience (Thu, 07 Dec 2006 14:50:18 GMT)
Cedars-Sinai Deploys Sun
SANTA CLARA, Calif. (Thu, 07 Dec 2006 15:23:33 GMT)
Supercomputing equipment to advance the frontiers of computational biology
Troy, N.Y. -- Researchers at Rensselaer Polytechnic Institute will continue to advance the frontiers of computational science with the help of IBM's Blue Gene supercomputer. (Thu, 07 Dec 2006 16:27:00 GMT)
Dr. S.M. Faruque, Scientist and Head, Molecular Genetics Laboratory of LSD, ICDDR,B received TWAS Award in Brazil
TWAS, the Academy of Sciences for the Developing World, has announced its 2005 prize winners. The annual TWAS Prizes, awarded in eight fields of scientific research, rank among the highest scientific accolades given to scientists in developing countries. (Thu, 07 Dec 2006 18:36:52 GMT)
eGene Awarded Taiwanese Patent 'MULTI-CHANNEL BIO-SEPARATION CARTRIDGE'
IRVINE, Calif.----eGene Inc. , a leading biotechnology company and developer of a compact and automated digital genetic analyzer, announced today that the Company has received confirmation from the Taiwan Patent Office of its decision to grant a patent for the "Multi-channel bio-separation cartridge." (Thu, 07 Dec 2006 18:56:00 GMT)
Biopsy Marker May Predict Breast Cancer's Course
Title: Biopsy Marker May Predict Breast Cancer's Course Category: Health News Created: 12/7/2006 2:06:00 AM Last Editorial Review: 12/7/2006 2:05:32 AM (Thu, 07 Dec 2006 20:34:37 GMT)
Microsoft Builds Relationships in Synthetic Biology
December 07, 2006 | Microsoft Research (MSR) has launched a new funding initiative in the promising but controversial field of computational challenges in synthetic biology. (Thu, 07 Dec 2006 20:44:03 GMT)
Supercomputing Equipment To Advance the Frontiers of Computational Biology
Researchers at Rensselaer will continue to advance the frontiers of computational science with the help of IBM's Blue Gene supercomputer. Awarded under IBM's Shared University Research (SUR) program, this Blue Gene will complement the $100 million partnership between Rensselaer, IBM, and New York state to create one of the world's most powerful university-based supercomputing centers. (Thu, 07 Dec 2006 21:17:40 GMT)
QuantRx(R) Biomedical Strengthens Financial Position
QuantRx® Biomedical Corporation, an emerging leader in the research and development of medical diagnostic platforms and products, today announced the completion of transactions that have strengthened the company's financial position. As a result of its stronger balance sheet, QuantRx will accelerate its growth initiatives and investment in its medical diagnostic intellectual property portfolio. (Thu, 07 Dec 2006 21:22:00 GMT)
From A Lowly Yeast, Researchers Divine A Clue To Human Disease
Working with a common form of brewer's yeast, University of Wisconsin-Madison researchers have uncovered novel functions of a key protein that allow it to act as a master regulatory switch -- a control that determines gene activity and that, when malfunctioning in humans, may contribute to serious neurological disorders. (Thu, 07 Dec 2006 22:12:12 GMT)
Sea Urchin Genome Suprisingly Similar To Man And May Hold Key To Cures
Sea urchins are small and spiny. They have no eyes or ears and yet their genome is very similar to humans' and my hold the key to preventing and curing diseases such as Alzheimer's and Parkinsons. (Thu, 07 Dec 2006 22:12:23 GMT)
UA proposes hospital and cancer center for downtown Phoenix
The University of Arizona College of Medicine and Banner Health are proposing that Banner build a hospital next to the college's downtown Phoenix biomedical campus and a comprehensive cancer center nearby. (Fri, 08 Dec 2006 00:24:00 GMT)
Genome institute to help innovators with start-up funds
New Delhi: India's premier Institute of Genomics and Integrative Biology (IGIB) is planning to launch a scheme to attract and help innovators in biotech and biogenomics start their own enterprise. (Fri, 08 Dec 2006 05:09:27 GMT)
New clue to cause of Alzheimer's
After decades of going after a sticky substance called beta amyloid that accumulates in the brains of Alzheimer's patients, scientists in Manhattan have discovered a new protein that may play a critical role in the disease process and offer possible treatments. (Fri, 08 Dec 2006 05:11:12 GMT)
New bridge to be funded by graduate of Princeton
PRINCETON TOWNSHIP -- A 1964 Princeton University graduate will bankroll most of the cost for the university's planned pedestrian gateway bridge over Washington Road, the university announced yesterday. (Fri, 08 Dec 2006 05:21:41 GMT)
Phoenix research group paying its way
A new study commissioned by TGen shows the downtown Phoenix-based research group last year returned $21.7 million to Arizona's economy and created 220 jobs. (Fri, 08 Dec 2006 07:28:17 GMT)
Banner, UA upset hospital debate
The University of Arizona and Banner Health want to team up to build a hospital on the downtown biomedical campus, a move that would threaten efforts to build a new county hospital in the area. (Fri, 08 Dec 2006 09:40:20 GMT)
Acacia Technologies Licenses Multi-Dimensional Bar Code Technology to Capital One
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that VData, LLC, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has entered into a license with Capital One covering a portfolio of patents that apply to certain multi-dimensional bar codes. (Fri, 08 Dec 2006 11:00:00 GMT)
health briefs
After decades of going after a sticky substance called beta amyloid that accumulates in the brains of Alzheimer's patients, scientists in Manhattan have discovered a new protein that might play a critical role in the disease process and offer possible treatments. (Fri, 08 Dec 2006 11:53:39 GMT)
DNAPrint Pharmaceuticals / Harvard Study Shows PT-401 to Be Three Times More Potent Than Conventional EPOs in Treating
DNAPrint Genomics, Inc. today announced the results of preclinical studies conducted by the Company and Harvard Medical School on the Company's proprietary PT-401 protein. The studies demonstrate that PT-401 is three times more effective than conventional EPO treatments, and conclude that PT-401 has "biological activities superior to those of EPO monomer, suggesting important therapeutic (Fri, 08 Dec 2006 12:00:00 GMT)
Acacia Technologies Licenses Multi-Dimensional Bar Code Technology to Capital One
NEWPORT BEACH, Calif., (Fri, 08 Dec 2006 12:24:39 GMT)
A Review of Apple's Strategic Weaknesses
The collective Apple community has been so intoxicated by the iPod, the success of the iTunes Store, MacBook sales, and excellent Mac OS X security that no one is reflecting on the areas where Apple is vulnerable. Perhaps it's unpleasant to think about, but neither do we want to live in a state of denial. So here are some areas where I think Apple should pay more attention (Fri, 08 Dec 2006 13:06:20 GMT)
Unfolding The Genetic Code: First Molecular Simulation Of A Long DNA Strand Shows Unexpected ...
Virginia Tech researchers used novel methodology and the university's System X supercomputer to carry out what is probably the first simulation that explores full range of motions of a DNA strand of 147 base pairs, the length that is required to form the fundamental unit of DNA packing in the living cells -- the nucleosome. Contrary to a long-held belief that DNA is hard to bend, the simulation (Fri, 08 Dec 2006 13:10:43 GMT)
Chemists Create 'Nanorobotic' Arm To Operate Within DNA Sequence
New York University chemistry professor Nadrian C. Seeman and his graduate student Baoquan Ding have developed a DNA cassette through which a nanomechanical device can be inserted and function within a DNA array, allowing for the motion of a nanorobotic arm. The results mark the first time scientists have been able to employ a functional nanotechnology device within a DNA array. (Fri, 08 Dec 2006 13:11:03 GMT)
CombiMatrix Group to Receive $10 Million from Acacia Research Registered Direct Offering
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that it has obtained commitments to purchase approximately $10 million of its Acacia Research-CombiMatrix common stock and warrants in a registered direct offering. (Fri, 08 Dec 2006 15:07:00 GMT)
Genomics Advocate von Eschenbach Confirmed as FDA Commissioner
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb? Register quickly here for your free subscription. (Fri, 08 Dec 2006 15:46:23 GMT)
DNAPrint Pharmaceuticals / Harvard Study Shows PT-401 to Be Three Times More Potent Than Conventional EPOs in Treating
DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced the results of preclinical studies conducted by the Company and Harvard Medical School on the Company's proprietary PT-401 protein. (Fri, 08 Dec 2006 16:31:06 GMT)
Researchers in Montréal and the US create model of key immune-system component
Montréal, December 8, 2006 -- Researchers at Université de Montréal, working with teams at Massachusetts General Hospital and Johns Hopkins University, have made a major breakthrough in understanding an essential aspect of the immune system. (Fri, 08 Dec 2006 17:42:00 GMT)
UAMS Researchers Helping to Unlock a Protein Code With Potential for Treating Disease
Molecular biologists at the University of Arkansas for Medical Sciences recently uncovered some of the first evidence for proteins that can read and write a "protein code," providing a possible pathway to new treatments for diseases such as cancer at the genetic level. (Fri, 08 Dec 2006 18:34:00 GMT)
M. Somasekhar
It's `Europe calling', for Indian pharma and biotech companies, especially from Hyderabad. In just about a year, half a dozen companies have either acquired companies, have forged license agreements or been acquired. (Fri, 08 Dec 2006 20:18:45 GMT)
Mapping The Wake Of A Pending Quake: Another Sumatra Tsunami Likely In Coming Decades
Research into ancient earthquakes by scientists at USC and Caltech shows that within the next few decades another tsunami from another giant earthquake is likely to flood densely populated sections of western coastal Sumatra, south of those that devastated by the tsunami of Dec. 26, 2004. (Fri, 08 Dec 2006 23:10:42 GMT)
Aggressive Stem Cells Might Improve Transplant Outcome
Investigators at St. Jude Children's Research Hospital have demonstrated in mice a way that might reduce the time it takes for a bone marrow transplant to rebuild a child's immune system, and so reduce the risk of potentially fatal virus infections that can occur during this time. (Fri, 08 Dec 2006 23:10:52 GMT)
Stocks in the news
Increased dividends: Quarterly unless noted otherwise; Acadia Realty Tr .20 from .185; Apollo Invest Cp .50 from .47; Applebees Intl .22A from .20A; Axis Capital Hldg .165 from .15; Bank of Nova Scotia g .42 from .39; Borders Group .11 from .10; Bowl America A .145 from .14; Capital Source Inc .55 from .49; Collector Universe .12 from .08; Communication Sys .10 from 09; DTE Energy .53 from .515; (Sat, 09 Dec 2006 10:51:42 GMT)
Regents recognize outstanding service
Wick Communications co-owner Robert Wick was honored by the Arizona Board of Regents with the 2006 Regents’ Award for Outstanding Service to Higher Education. (Sat, 09 Dec 2006 11:00:15 GMT)
Dr. S.M. Faruque, Scientist and Head, Molecular Genetics Laboratory of LSD, ICDDR,B received TWAS Award in Brazil
TWAS, the Academy of Sciences for the Developing World, has announced its 2005 prize winners. The annual TWAS Prizes, awarded in eight fields of scientific research, rank among the highest scientific accolades given to scientists in developing countries. (Sat, 09 Dec 2006 18:32:12 GMT)
Kannada Nudi Kannada Gadi Jagruti Jatha:
Inauguration of convention of representatives from border taluks by poet G S Shivarudrappa 11 am; submission of report to government on the situation in border areas, Chief Minister H D Kumaraswamy, Home Minister M P Prakash, participate, Secretariat Club, Cubbon Park, 4 pm. (Sat, 09 Dec 2006 20:59:00 GMT)
MHPCC supercomputer among world’s fastest
KIHEI – The numbers are like cosmological distances – too big to really comprehend: The new Dell PowerEdge 1955 dedicated Friday at the Maui High Performance Computing Center has a maximum speed of 61 teraflops, memory of more than 353 terabytes. (Sat, 09 Dec 2006 22:13:26 GMT)
Antibiotics au naturel
Where combinatorial chemistry and genomics have stalled, could an exploration of untapped sources usher in a second golden age of antibiotic discovery? Cormac Sheridan investigates. (Sun, 10 Dec 2006 04:22:23 GMT)
Protein pathway may shed light on Alzheimer’s Discovery of protein pathway may shed light on Alzheimer’s
NEW YORK | Scientists have discovered a protein pathway that may play a critical role in Alzheimer’s disease and offer possible treatments. (Sun, 10 Dec 2006 08:31:12 GMT)
Banner, UA planning hospital for cancer care
Banner Health and the University of Arizona's nationally known cancer center announced a partnership Saturday to build a central Phoenix cancer hospital that they say could rival Memorial Sloan-Kettering in New York or M.D. Anderson in Houston. (Sun, 10 Dec 2006 08:55:32 GMT)
Protein's Tail May Be Flu Virus's Achilles Heel
New research from Rice University and the University of Texas at Austin (UT) has revealed a potential new target that drug makers can use to attack several strains of influenza, including those that cause bird flu. The research, published online December 6 by Nature, offers evidence of a potential drug target in a flu protein that plays a vital role in all strains of influenza A, including Hong (Sun, 10 Dec 2006 11:11:03 GMT)
Researchers Create Model Of Key Immune-system Component
Researchers at Université de Montréal, working with teams at Massachusetts General Hospital and Johns Hopkins University, have made a major breakthrough in understanding an essential aspect of the immune system. For the first time, using a systems biology approach, they have developed a model that facilitates the study of the function of the phagosome. The results of their study were published (Sun, 10 Dec 2006 11:11:13 GMT)
Researchers Developing Molecular Delivery Vehicles For Genetic Therapies
Researchers at New York University are working to develop molecular delivery vehicles that can be used to transport nucleic acids into diverse cell types, which may lead to eventual applications in genetic therapies. Their work is described as part of the cover story in the November 13 issue of the American Chemical Society publication Chemical and Engineering News. (Sun, 10 Dec 2006 11:12:03 GMT)
Solving Darwin's Dilemma: Oxygen May Be The Clue To First Appearance Of Large Animals
The sudden appearance of large animal fossils more than 500 million years ago -- a problem that perplexed even Charles Darwin and is commonly known as "Darwin's Dilemma" -- may be due to a huge increase of oxygen in the world's oceans, says Queen's paleontologist Guy Narbonne, an expert in the early evolution of animals and their ecosystems. (Sun, 10 Dec 2006 11:12:13 GMT)
Breast-Cancer Survival Predicted By Protein-Based Tumor Biomarker
The first and largest clinical trial of its kind confirms that a protein called p27 may be a valuable tool for predicting survival after a diagnosis of breast cancer.The findings, by lead author Peggy Porter, M.D., of Fred Hutchinson Cancer Research Center, in collaboration with colleagues from nine other institutions, appear in the Dec. 6 issue of the Journal of the National Cancer Institute. (Sun, 10 Dec 2006 15:10:47 GMT)
Finding Stress Points in Apple's Business Strategy
The collective Apple community has been so intoxicated by the iPod, the success of the iTunes Store, MacBook sales, and excellent Mac OS X security that no one is reflecting on the areas where Apple is vulnerable. Perhaps it's unpleasant to think about, but neither do we want to live in a state of denial. So here are some areas where I think Apple should pay more attention. (Sun, 10 Dec 2006 15:16:14 GMT)
NIAID media availability: Examining genetic variability of malaria parasite offers insight
WHAT: Back-to-back papers published online this week in Nature Genetics reveal important new details about the genetic variability of the malaria parasite and provide new clues for how it causes disease. (Sun, 10 Dec 2006 18:10:23 GMT)
Genetic map offers new tool for malaria research
Boston, MA and Cambridge, MA, Sun. December 10, 2006 -- An international research team announced today the completion of a genome-wide map that charts the genetic variability of the human malaria parasite Plasmodium falciparum. (Sun, 10 Dec 2006 18:11:23 GMT)
Dr. S.M. Faruque, Scientist and Head, Molecular Genetics Laboratory of LSD, ICDDR,B received TWAS Award in Brazil
TWAS, the Academy of Sciences for the Developing World, has announced its 2005 prize winners. The annual TWAS Prizes, awarded in eight fields of scientific research, rank among the highest scientific accolades given to scientists in developing countries. (Sun, 10 Dec 2006 18:32:01 GMT)
Genetic Map Offers New Tool for Malaria Research
Scientists create genome-scale map of genetic variation for malaria parasite; initial use unlocks genes involved in drug resistance. (Sun, 10 Dec 2006 19:29:39 GMT)
Banner Health OKs Valley Cancer Center: Facility to Be State's 2nd; Patients to Have Access to Clinical Trials
By Jill Redhage, The Tribune, Mesa, Ariz. Dec. 10--A unanimous vote Saturday morning by the 15 board members of Banner Health made plans a "go" for the creation of the Valley's first comprehensive cancer center. (Sun, 10 Dec 2006 23:14:03 GMT)
Discovery of new protein may help in Alzheimer's treatments
After decades of going after a sticky substance called beta amyloid that accumulates in the brains of Alzheimer's... (Mon, 11 Dec 2006 00:51:35 GMT)
Blood test in the works to detect breast cancer
Phoenix company is conducting a clinical trial for a blood test to detect breast cancer. The plan is to offer the test widely next year. (Mon, 11 Dec 2006 04:19:53 GMT)
Three Bay Area labs bid for energy research cash
Just when we finally started to understand proteomics and gene splicing, it turns out biopharma is so last year. Now, three national laboratories are hoping to use the same technologies to turn alternative energy into the Bay Area's next boom industry. (Mon, 11 Dec 2006 05:06:08 GMT)
Gene Discovered by Researchers Tied to Pancreatic Cancer
A gene discovered by researchers at the University of North Carolina at Chapel Hill School of Medicine has been associated with two forms of pancreatic cancer, according to a study by an international group of researchers. (Mon, 11 Dec 2006 05:29:49 GMT)
A Brassy Move
The sound of a trumpet no longer echoes through Harvard’s Center for Systems Biology. After nearly three decades of work in science, the center’s executive director left Harvard to become a professional musician. (Mon, 11 Dec 2006 07:50:19 GMT)
New Nanomechanical Method For Detecting Disease- And Treatment-Relevant Genes
Innovative technique offers new possibilities for matching drug treatments more closely to patient needsResearchers from the National Centre of Competence in Research at the newly established Swiss Nanoscience Institute (SNI) in Basel, together with Roche scientists, have developed an innovative method for the rapid and sensitive detection of disease- and treatment-relevant genes. [click link for (Mon, 11 Dec 2006 08:14:08 GMT)
(AFX UK Focus) 2006-12-11 08:03 GMT: Galapagos to get up to 2.4 mln eur to work on medicines for Lou Gehrig disease
AMSTERDAM (AFX) - Galapagos Genomics NV said it has signed a two-year agreement worth up to 2.4 mln eur with The ALS Association of the US, which has the goal of finding medicines to treat amyotrofic lateral sclerosis (ALS), better known as Lou Gehrig's disease. (Mon, 11 Dec 2006 08:22:37 GMT)
Genting Consortium: Resorts World at Sentosa will boost economy
SINGAPORE: The Genting International-Star Cruises Consortium, who on Friday won the bid to build the Integrated Resort at Sentosa, has said its proposed Resorts World at Sentosa will bring significant contributions to the Singapore economy. (Mon, 11 Dec 2006 08:41:11 GMT)
NIH Funds Are for Research
Naysayers argue that embryonic stem-cell research deserves no federal funding because it has shown no success. Neither have other heavily funded research programs. By Brandon Keim. (Mon, 11 Dec 2006 10:17:05 GMT)
iHorizons to develop home-grown software at Qatar Science & Technology Park
Qatari software company iHorizons announced today that it will establish a research and development company at Qatar Science & Technology Park. (Mon, 11 Dec 2006 10:37:20 GMT)
AutoGenomics Submits 510K to the FDA For 2C9 / VKORC1 to Assess Warfarin Sensitivity
AutoGenomics, a leader in developing automated molecular testing solutions, announced today that it has submitted a 510K application to the FDA in October 2006 for its CYP450 2C9 / VKORC1 assay on its INFINITI System. (Mon, 11 Dec 2006 11:00:00 GMT)
Research and Markets: Gain Insight into the Historical Perspective to Drug Discovery, Such as the Pioneering Work of
DUBLIN, Ireland----Research and Markets has announced the addition of Novel Targets in Drug Discovery to their offering. (Mon, 11 Dec 2006 11:38:00 GMT)
The MBAs who changed the world?
When most MBA students take on practical business exercises their main ambitions are a bit of useful experience and a good grade. (Mon, 11 Dec 2006 12:50:05 GMT)
Bionovo Expands Scientific Advisory Board
Bionovo Inc. announced today that Dr. Terry Speed will join the company's scientific advisory board. (Mon, 11 Dec 2006 13:00:00 GMT)
Invitrogen Features New Scientific Online Resources at American Society for Cell Biology (ASCB) Meeting
SAN DIEGO----Invitrogen Corporation , a leader in life science research, today introduced the newest member of its free online scientific resource collection, iGene, a platform that allows researchers to conveniently search for experimental reagents by gene or protein. (Mon, 11 Dec 2006 13:00:00 GMT)
American Chemical Society's Weekly PressPac -- December 6, 2006
Here is the latest American Chemical Society (ACS) News Service Weekly press package (PressPac) with reports selected from 35 major peer-reviewed journals and Chemical & Engineering News. (Mon, 11 Dec 2006 13:10:17 GMT)
AutoGenomics Submits 510K to the FDA For 2C9 / VKORC1 to Assess Warfarin Sensitivity
CARLSBAD, Calif., Dec. 11 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that it has submitted a 510K application to the FDA in October 2006 for its CYP450 2C9 / VKORC1 assay on its INFINITI(TM) System. (Mon, 11 Dec 2006 14:18:47 GMT)
Covalys Announces CTI Project Targeting First Use of SNAP-tag in Living Mice
Witterswil, Switzerland (PRWeb) December 11, 2006 -- Covalys (www. (Mon, 11 Dec 2006 14:25:00 GMT)
Fear of migraine destroys quality of life for men
The unpredictability of symptoms and apprehension associated with living with migraine is limiting mens' lives, according to research from Griffith University’s Genomics Research Centre. (Mon, 11 Dec 2006 14:55:19 GMT)
Mutant mouse provides insights into breast cancer
By discovering a mutant mouse that is highly susceptible to mammary tumors, Cornell researchers have found a novel potential link between genetic defects in DNA replication (copying) and breast cancer. (Mon, 11 Dec 2006 15:24:53 GMT)
Invitrogen Features New Scientific Online Resources At American Society For Cell Biology (ASCB) Meeting
Invitrogen Corporation, a leader in life science research, today introduced the newest member of its free online scientific resource collection, iGene, a platform that allows researchers to conveniently search for experimental reagents by gene or protein (Mon, 11 Dec 2006 15:32:57 GMT)
Covalys Announces CTI Project Targeting First Use of SNAP-tag in Living Mice
Covalys announces a joint CTI-project with the Ecole Polytechnique Fédérale de Lausanne targeting the use of ‘SNAP-tag for selective labeling of fusion proteins in living mice’. (PRWeb Dec 11, 2006) Post Comment:Trackback URL: http://www.prweb.com/chachingp (Mon, 11 Dec 2006 15:44:56 GMT)
AMEX Accepts Matritech's Plan to Regain Compliance with Continued Listing Standards
NEWTON, Mass.----Matritech , a leading marketer and developer of protein-based diagnostic products for the early detection of cancer, today announced that the American Stock Exchange has accepted the Company's plan to regain compliance with continued listing standards of AMEX. (Mon, 11 Dec 2006 16:00:00 GMT)
Evolution And The Workaround: Do Aggressive Cancers Pile Up Extra Chromosomes As Genomic ...
At the American Society for Cell Biology 2006 conference, scientists will describe new research indicating that both yeast and cancer cells evolve chromosome duplications to work around lethal stresses. (Mon, 11 Dec 2006 16:10:42 GMT)
Research and Markets: Key Company Data Now Available on Ariadne Genomics
DUBLIN, Ireland----Research and Markets has announced the addition of Ariadne Genomics - Company Profile to their offering. (Mon, 11 Dec 2006 17:00:00 GMT)
Regents recognize outstanding service
Wick Communications co-owner Robert Wick was honored by the Arizona Board of Regents with the 2006 Regents’ Award for Outstanding Service to Higher Education. (Mon, 11 Dec 2006 17:00:16 GMT)
Bio-IT Briefs
December 11, 2006 | Researchers at Rensselaer Polytechnic Institute will continue to advance the frontiers of computational science with the help of IBM’s Blue Gene supercomputer. (Mon, 11 Dec 2006 17:29:05 GMT)
Dr. S.M. Faruque, Scientist and Head, Molecular Genetics Laboratory of LSD, ICDDR,B received TWAS Award in Brazil
TWAS, the Academy of Sciences for the Developing World, has announced its 2005 prize winners. The annual TWAS Prizes, awarded in eight fields of scientific research, rank among the highest scientific accolades given to scientists in developing countries. (Mon, 11 Dec 2006 18:32:13 GMT)
Dr. Hans-Joachim Bohm Named President of Roche Palo Alto
Roche has announced that Hans-Joachim Bohm, Ph.D., has been appointed president of Roche Palo Alto LLC. As president, Dr. Bohm is responsible for managing a research site focused on early discovery in three of Roche's therapy areas: Virology, Neurosciences and Autoimmunity, Inflammation and Transplantation. (Mon, 11 Dec 2006 18:46:00 GMT)
Genomics dealing with great expectations
That whole human genome thing may have been a big misunderstanding. In the six-plus years since researchers completed mapping the human genome to much fanfare, many high-profile companies based on the science have yet to show a profit. (Mon, 11 Dec 2006 20:08:58 GMT)
Pioneers in field of functional genomics work toward gene therapy for vision defects
"Primates and humans have three photoreceptors and can only see four basic colors, red, green, blue and yellow," says Jay Neitz, Ph.D. "Birds, fish and reptiles have four photoreceptors, allowing them to see things we cannot. (Mon, 11 Dec 2006 22:10:22 GMT)
Columbia University licenses next-generation DNA sequencing technology
Columbia University announces today that it recently executed an exclusive license agreement for a next generation DNA sequencing technology to Intelligent Bio-Systems (IBS), Inc. This innovative DNA-sequencing technology was invented by Dr. Jingyue Ju, professor of Chemical Engineering and head of DNA Sequencing and Chemical Biology at the Judith P. Sulzberger, M.D. Columbia Genome Center at (Mon, 11 Dec 2006 22:12:07 GMT)
Pioneers in Field of Functional Genomics Work Toward Gene Therapy for Vision Defects
For millennia anglers have wondered how fish see colors, and the rainbow of lures in every bait shop reveal that we're still guessing. But, in fish, reptiles and birds, that's all we can do for now, according to husband and wife vision researchers, Drs. Jay and Maureen Neitz at the Medical College of Wisconsin in Milwaukee. (Tue, 12 Dec 2006 01:29:39 GMT)
A Cryptologist Takes a Crack at Deciphering DNA?s Deep Secrets
Nick Patterson, a self-professed ?data-guy,? explores the link between humans and chimpanzees. (Tue, 12 Dec 2006 03:21:50 GMT)
Protein Biomarker "Fingerprint" in Spinal Fluid Could Spot Alzheimer's Disease
Today, physicians must rely on their clinical judgment to decide whether a patient has Alzheimer's rather than some other form of dementia. In many cases, the diagnosis remains uncertain until autopsy. Now scientists have identified a neurochemical "fingerprint" which may someday be used to identify patients living with Alzheimer's disease. (Tue, 12 Dec 2006 05:17:29 GMT)
Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease
ITHACA, N.Y. — Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease. (Tue, 12 Dec 2006 05:27:00 GMT)
Spinal fluid may hold key to Alzheimer's
Scientists appear to have found a fingerprint of Alzheimer’s disease lurking in patients’ spinal fluid, a step toward a long-awaited test for the memory-robbing disease that today can be diagnosed definitively only at autopsy. (Tue, 12 Dec 2006 06:17:51 GMT)
Protein 'Fingerprint' in Spinal Fluid Could Spot Alzheimer's Disease
Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease. The research will be published in the December online-edition of the journal Annals of (Tue, 12 Dec 2006 06:29:39 GMT)
Software firm plans technology park
Qatari software company iHorizons will establish a research and development company at Qatar Science and Technology Park (QSTP), it was announced yesterday. (Tue, 12 Dec 2006 07:14:06 GMT)
CSIR supercomputer fights HIV
A supercomptuer has been enlisted to fast track the process of finding a cure for some of the country's most serious illnesses. (Tue, 12 Dec 2006 08:04:18 GMT)
Epigenomics AG: PITX2 Prostate Cancer Molecular Classification Test Successfully Transferred to Affymetrix Diagnostic
BERLIN and SEATTLE, Dec. 12, 2006 -- Epigenomics AG announced today that it successfully transferred its prostate cancer molecular classification test, based on the PITX2 biomarker, to the Affymetrix GeneChip platform. (Tue, 12 Dec 2006 08:25:42 GMT)
Findings may lead to Alzheimer's test
Scientists appear to have found a fingerprint of Alzheimer's disease lurking in patients' spinal fluid, a step toward a long-awaited test for the memory-robbing disease that today can be definitively diagnosed only at autopsy. (Tue, 12 Dec 2006 11:12:19 GMT)
40th Governor's Conference on Agriculture Begins with a Showcase of Missouri Foods
The 2006 Missouri Governor's Conference on Agriculture began yesterday with A Taste of AgriMissouri - an array of Missouri 's finest foods and beverages. (Tue, 12 Dec 2006 11:56:19 GMT)
Possible fingerprint of Alzheimer's found
Scientists appear to have found a fingerprint of Alzheimer's disease lurking in patients' spinal fluid, a step toward a long-awaited test for the memory-robbing disease that today can be diagnosed definitively only at autopsy. (Tue, 12 Dec 2006 12:04:35 GMT)
Protein 'bar code' in spinal fluid could lead to first diagnostic test for Alzheimer's patients, researchers say
Imagine the ability to use a simple spinal tap to diagnose Alzheimer's in people living with the disease. With the power of proteomics -- the study of the structure and function of proteins -- that ability could be close at hand. (Tue, 12 Dec 2006 12:31:46 GMT)
Chang Gung University Upgrades and Extends Their Agreement With GeneGo to Access MetaCore and MapEditor
GeneGo, Inc., a leading provider of software and databases for systems biology and pathway analysis, today announced that Chang Gung University , Taiwan has upgraded their MetaCore web portal license to a permanent in house server installation. (Tue, 12 Dec 2006 13:00:00 GMT)
Invitrogen and Blue Heron Biotechnology Enter into Strategic Development and Distribution Relationship
CARLSBAD, Calif.----Invitrogen Corporation , a global leader in life sciences, today announced they have entered into a strategic development and distribution relationship with Blue Heron Biotechnology. (Tue, 12 Dec 2006 13:00:00 GMT)
1st International Conference On Biomolecular Engineering To Be Held In January
The Society for Biological Engineering (SBE) will hold its first International Conference on Biomolecular Engineering from January 14-18 and feature Dr. J. Craig Venter, one of the leading scientists of the 21st Century for his pioneering work with the human genome (Tue, 12 Dec 2006 13:02:41 GMT)
Genomics: Pioneers In Field Of Functional Genomics Work Toward Gene Therapy For Vision Defects
"Primates and humans have three photoreceptors and can only see four basic colors, red, green, blue and yellow," says Jay Neitz, Ph.D. "Birds, fish and reptiles have four photoreceptors, allowing them to see things we cannot (Tue, 12 Dec 2006 13:03:06 GMT)
Possible Alzheimer's Fingerprint Found in Spinal Fluid
Scientists may have found an identifying sign of Alzheimer's disease in patients' spinal fluid (Tue, 12 Dec 2006 13:14:02 GMT)
Molecular Biometrics Secures Broad Patent Portfolio for Metabolomics Technology Platform in All Biomedical Applications
Molecular Biometrics, a privately held metabolomics company, today announced the completion of a licensing agreement with McGill University, Montreal, Canada, that secures a broad patent portfolio for the company's metabolomics technology platform. The Company also announced that it is expediting the development of its lead indication of embryo selection for in-vitro fertilization and plans to ... (Tue, 12 Dec 2006 13:20:00 GMT)
Helicos BioSciences Announces Additions to Scientific Advisory Board
CAMBRIDGE, Mass.----Helicos BioSciences, pioneering new frontiers in genetic analysis, today announced the addition of John Quackenbush, Ph.D. of Dana-Farber Cancer Institute, and David Liu, Ph.D. of Harvard University, to its scientific advisory board. (Tue, 12 Dec 2006 13:30:00 GMT)
Unfolding The Genetic Code
It turns out that sequencing the human genome - determining the order of DNA building blocks -- has not completely cracked the code of how DNA directs various cellular processes. In addition to the sequence of the base pairs, the instructions are in the packaging - how DNA is folded within a cell. [click link for full article] (Tue, 12 Dec 2006 14:12:32 GMT)
Scientists Find Possible Alzheimer's Fingerprint
Scientists appear to have found a fingerprint of Alzheimer's disease lurking in patients' spinal fluid, a step toward a test for the memory-robbing disease. (Tue, 12 Dec 2006 14:55:54 GMT)
New Company Launched To Promote London's Genetic Research Capability
London Genetics, a specialist agency created to facilitate partnerships between industry and academic centres of excellence in genetics and genomics-based research across London, is to be launched today at the Genesis meeting (Tue, 12 Dec 2006 15:17:58 GMT)
Toward A Noninvasive Diagnostic Test For Serious Infections In Pregnancy
Scientists have discovered the basis for a noninvasive test to diagnose common infections in pregnant women that are a major cause of premature births and infant deaths. The University of Washington's Michael G. Gravett and colleagues are reporting identification of protein biomarkers for these hard-to-diagnose infections of the amniotic fluid, which surrounds the fetus prior to birth. (Tue, 12 Dec 2006 16:04:31 GMT)
First Familial Pancreatic Cancer Gene Identified
At least 10 percent of pancreatic cancers are thought to be familial, i.e., caused by inherited genetic mutations. The responsible genes have so far remained elusive, but one of the research teams that had been on a pancreatic cancer gene hunt for years now reports success: Teri Brentnall (University of Washington), David Whitcomb (University of Pittsburgh), and colleagues publish the ... (Tue, 12 Dec 2006 16:04:39 GMT)
S.African health researchers get new hi-tech supertool
Source: Reuters By Sarah McGregor JOHANNESBURG, Dec 12 (Reuters) - Scientists in South Africa unveiled the country's most powerful weapon yet in their fight against AIDS, malaria and tuberculosis when they switched ... (Tue, 12 Dec 2006 16:12:09 GMT)
Scientists find possible fingerprint of Alzheimer's in spinal fluid
WASHINGTON (AP) -- Scientists appear to have found a fingerprint of Alzheimer's disease lurking in patients' spinal fluid, a step toward a long-awaited test for the memory-robbing disease that today can be diagnosed definitively only at autopsy. (Tue, 12 Dec 2006 16:24:39 GMT)
Burnham Institute for Medical Research announces affiliation with UC Santa Barbara
Burnham-UCSB home to "Vascular Mapping Center" founded by Burnham's Distinguished Professor, Erkki Ruoslahti, M.D., Ph.D. (Tue, 12 Dec 2006 17:05:04 GMT)
Family Tree DNA takes root in Europe
Family Tree DNA has branched out with a new office in Zurich, Switzerland -- its first outside of the United States. (Tue, 12 Dec 2006 17:34:57 GMT)
Vanderbilt University and the National Foundation for Cancer Research Launch New Center for Proteomics and Drug Actions
NASHVILLE, Tenn. & BETHESDA, Md.----Vanderbilt University Medical Center and the National Foundation for Cancer Research announced today the establishment of a new cancer research center that will be linked in with seven others around the world. (Tue, 12 Dec 2006 17:45:00 GMT)
S.African health researchers get new hi-tech supertool
Scientists in South Africa unveiled the country's most powerful weapon yet in their fight against AIDS, malaria and tuberculosis when they switched on a new supercomputer dedicated to scientific research this week. (Tue, 12 Dec 2006 17:56:57 GMT)
University of Washington-led team discovers a gene
Seattle, WA and New York, NY (Dec. 12, 2006) - An international group of researchers has discovered that the mutated form of a gene called Palladin causes familial pancreatic cancer. (Tue, 12 Dec 2006 18:49:53 GMT)
Alzheimer's Marker May Be In Spinal Fluid
The presence of a pattern of 23 proteins seems to identify Alzheimer's disease, which at present can only be confirmed during an autopsy. But researchers caution that much more testing is needed before this tool can be used. (Tue, 12 Dec 2006 19:02:31 GMT)
Alzheimer’s Disease May Be Identified by Protein ‘Fingerprint’ in Spinal Fluid
December 12, 2006 – The battle against Alzheimer’s disease, the mind-clogging ailment most feared by senior citizens – has often focused on finding a means of early detection, when there seems to be more of an opportunity for treatment. (Tue, 12 Dec 2006 19:09:20 GMT)
Vanderbilt nets grant to study protein interaction with cancer
Vanderbilt University Medical Center has received a five-year, $1 million grant from the National Foundation for Cancer Research to apply proteomics to cancer drug discovery. (Tue, 12 Dec 2006 19:39:00 GMT)
Vanderbilt, NFCR Building Proteomics Center to Study Cancer Dxs, Rxs
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb? Register quickly here for your free subscription. (Tue, 12 Dec 2006 20:14:47 GMT)
Researchers discover a gene that causes familial pancreatic cancer
An international group of researchers has discovered that the mutated form of a gene called Palladin causes familial pancreatic cancer. The findings, published online today (Dec. 12) in the peer-reviewed journal PLoS-Medicine, may help explain why the disease is so deadly. The research project was led by Dr. Teri Brentnall, University of Washington associate professor of medicine, and supported ... (Tue, 12 Dec 2006 21:33:34 GMT)
Fill your car with pond scum in 2010
Blog: Algae. I scrape it out of my daughter's goldfish tank every few days, but someday those single cell plants could be powering cars.LiveFuels... (Tue, 12 Dec 2006 22:10:15 GMT)
Varsity may relax Ph.D. norm for faculty
Relaxation will apply to computer science, biotechnology, bioinformatics (Tue, 12 Dec 2006 22:14:29 GMT)
Speedy computer makes Aids research easier
Scientists have unveiled one of South Africa's most powerful weapons in the fight against Aids, malaria and tuberculosis: a new supercomputer dedicated to research. Sarah McGregor reports... (Tue, 12 Dec 2006 23:14:22 GMT)
Professors of the Year elected in Cologne (12/12/2006)
Ann-Kristin Achleitner, Professor for Entrepreneurial Finance at the Technical University in Munich, Karl-Rudolf Korte, Professor for Political Science at the University of Duisburg-Essen, Gisbert Schneider, Professor for Chemistry and Bioinformatics at the University of Frankfurt a.M., and Klaus A. Wolf, Professor for Media Systems at the University of Applied Sciences in Regensburg are the ... (Tue, 12 Dec 2006 23:17:04 GMT)
UW-led team discovers gene for inherited pancreatic cancer
An international group of researchers has discovered that the mutated form of a gene called Palladin causes familial pancreatic cancer. The findings, published online December 12 in the journal PLoS-Medicine, may help explain why the disease is so deadly. (Tue, 12 Dec 2006 23:20:59 GMT)
Team Discovers a Gene That Causes Familial Pancreatic Cancer
An international group of researchers has discovered that the mutated form of a gene called Palladin causes familial pancreatic cancer. The findings, published online today (Dec. 12) in the peer-reviewed journal PLoS-Medicine, may help explain why the disease is so deadly. (Tue, 12 Dec 2006 23:24:31 GMT)
iHorizons sets up R&D firm at QSTP
DOHA • Qatari software company iHorizons announced yesterday that it will establish a research and development company at the Qatar Science & Technology Park (QSTP). (Tue, 12 Dec 2006 23:43:40 GMT)
Protein 'Bar Code' In Spinal Fluid Could Lead To First Diagnostic Test For Alzheimer's Patients
Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease. The research will be published in the December online edition of the journal Annals of ... (Wed, 13 Dec 2006 01:05:19 GMT)
Possible Alzheimer's fingerprint found
Scientists appear to have found a fingerprint of Alzheimer's disease lurking in patients' spinal fluid, a step toward a long-awaited test for the memory-robbing disease that today can be diagnosed definitively only at autopsy. (Wed, 13 Dec 2006 01:16:05 GMT)
Possible Alzheimer's Fingerprint Found
Scientists appear to have found a fingerprint of Alzheimer's disease lurking in patients' spinal fluid, a step toward a long-awaited test for the memory-robbing disease that today can be diagnosed definitively only at autopsy. Researchers at New York's... (Wed, 13 Dec 2006 01:28:56 GMT)
Bioscience effort off to a big start
Four years into statewide plans to grow its biosciences, Arizona has added 10,700 jobs, increased research grants by 30 percent, and created 33 new bioscience-related firms. (Wed, 13 Dec 2006 02:06:19 GMT)
Qatar: iHorizons sets up R&D firm at QSTP
13 December 2006 DOHA: Qatari software company iHorizons announced yesterday that it will establish a research and development company at the Qatar Science & Technology Park (QSTP). (Wed, 13 Dec 2006 05:21:32 GMT)
DNA analysis may soon be used to make better beef
Now an important shortcut is on the horizon, and Missouri's $1.5 billion beef-cattle business could be positioned to use DNA analysis. (Wed, 13 Dec 2006 06:01:02 GMT)
SA researchers get supertool
Scientists have unveiled a powerful weapon in their fight against Aids, malaria and tuberculosis - a supercomputer. (Wed, 13 Dec 2006 09:31:36 GMT)
New Report Describes Different Types of Biomarkers and Their Discovery Using Various '-Omics' Technologies Such as ...
DUBLIN, Ireland----Research and Markets has announced the addition of Biomarkers - Technologies, Markets and Companies to their offering. (Wed, 13 Dec 2006 11:44:00 GMT)
Practical Guide Covering the Full Scope of Key Concepts in Bioinformatics, from Databases to Predictive and Comparative ...
DUBLIN, Ireland----Research and Markets has announced the addition of "Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins, 3rd Edition" to their offering. (Wed, 13 Dec 2006 12:56:00 GMT)
Affymetrix and Sysmex Join Forces to Develop and Market In-Vitro Diagnostic Tests
SANTA CLARA, Calif.----Affymetrix Inc. announced today that it has signed two agreements with Sysmex Corporation of Kobe, Japan, to distribute, develop and market in-vitro diagnostic tests. (Wed, 13 Dec 2006 13:00:00 GMT)
Mount Sinai School of Medicine and EXACT Sciences Announce Publication of Multi-Center Study Results on Stool DNA ...
Mount Sinai School of Medicine and EXACT Sciences Corporation (NASDAQ: EXAS) announced today the publication of results from a prospective, multi-center study of stool DNA testing. (Wed, 13 Dec 2006 13:04:39 GMT)
New Report Describes Different Types of Biomarkers and Their Discovery Using Various '-Omics' Technologies Such As ...
Research and Markets (http://www.researchandmarkets has announced the addition of Biomarkers - Technologies, Markets and Companies to their offering. (Wed, 13 Dec 2006 13:06:30 GMT)
Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
New York, NY and Marlborough, MA - (December 13, 2006) -- Mount Sinai School of Medicine and EXACT Sciences Corporation (NASDAQ: EXAS) announced today the publication of results from a prospective, multi-center study of stool DNA testing. (Wed, 13 Dec 2006 15:10:08 GMT)
Previous 1 2 3 4 5 Next
